Pro-arrhythmic electrophysiological and structural remodelling in rheumatoid arthritis.
暂无分享,去创建一个
F. Ng | S. Sattler | J. Mason | K. Patel | T. Jones
[1] D. Judge,et al. Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy. , 2019, Circulation.
[2] M. Boutjdir,et al. Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin‐6–Mediated Changes in Connexin Expression , 2019, Journal of the American Heart Association.
[3] D. Paterson,et al. The autonomic nervous system and cardiac arrhythmias: current concepts and emerging therapies , 2019, Nature Reviews Cardiology.
[4] G. Kitas,et al. Cardiovascular magnetic resonance imaging pattern in patients with autoimmune rheumatic diseases and ventricular tachycardia with preserved ejection fraction. , 2019, International journal of cardiology.
[5] M. Boutjdir,et al. Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation , 2018, PloS one.
[6] J. Smolen,et al. Diagnosis and Management of Rheumatoid Arthritis: A Review , 2018, JAMA.
[7] M. Nahrendorf,et al. Cardioimmunology: the immune system in cardiac homeostasis and disease , 2018, Nature Reviews Immunology.
[8] M. Takei,et al. Heart Rate–corrected QT Interval Duration in Rheumatoid Arthritis and Its Reduction with Treatment with the Interleukin 6 Inhibitor Tocilizumab , 2018, The Journal of Rheumatology.
[9] M. Ciccarelli,et al. Cardiac eccentric remodeling in patients with rheumatoid arthritis , 2018, Scientific Reports.
[10] P. Camelliti,et al. Role of Non-Myocyte Gap Junctions and Connexin Hemichannels in Cardiovascular Health and Disease: Novel Therapeutic Targets? , 2018, International journal of molecular sciences.
[11] Monica Salerno,et al. Heart rate variability as predictive factor for sudden cardiac death , 2018, Aging.
[12] M. Huber-Lang,et al. Experimental blunt chest trauma-induced myocardial inflammation and alteration of gap-junction protein connexin 43 , 2017, PloS one.
[13] M. Takei,et al. Magnetic Resonance Imaging–Detected Myocardial Inflammation and Fibrosis in Rheumatoid Arthritis: Associations With Disease Characteristics and N‐Terminal Pro–Brain Natriuretic Peptide Levels , 2017, Arthritis care & research.
[14] Phang Boon Lim,et al. Sudden cardiac death in patients with rheumatoid arthritis , 2017, World journal of cardiology.
[15] R. D. de Boer,et al. From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities , 2017, Current Heart Failure Reports.
[16] K. Shivkumar,et al. Brugada syndrome—Malignant phenotype associated with acute cardiac inflammation? , 2017, HeartRhythm case reports.
[17] P. Tak,et al. Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis , 2017, Journal of internal medicine.
[18] M. Boutjdir,et al. Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes , 2017, Heart.
[19] Andrej J. Savol,et al. Macrophages Facilitate Electrical Conduction in the Heart , 2017, Cell.
[20] S. Singla,et al. Prevalence of Autonomic Neuropathy in Patients of Rheumatoid Arthritis and Its Correlation with Disease Severity. , 2017, Journal of clinical and diagnostic research : JCDR.
[21] G. Firestein,et al. Immunopathogenesis of Rheumatoid Arthritis. , 2017, Immunity.
[22] Hong Zhang,et al. Proarrhythmic risk and determinants of cardiac autonomic dysfunction in collagen-induced arthritis rats , 2016, BMC Musculoskeletal Disorders.
[23] B. Yan,et al. Electrophysiological mechanisms of long and short QT syndromes , 2016, International journal of cardiology. Heart & vasculature.
[24] Rosana A Bassani,et al. Macrophage-dependent IL-1β production induces cardiac arrhythmias in diabetic mice , 2016, Nature Communications.
[25] Javier Martín,et al. Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers. , 2016, Autoimmunity reviews.
[26] G. Lip,et al. Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis , 2016, The Journal of physiology.
[27] M. Boutjdir,et al. Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis , 2016, Front. Cardiovasc. Med..
[28] M. Maes,et al. Connexins and their channels in inflammation , 2016, Critical reviews in biochemistry and molecular biology.
[29] P. Lazzerini,et al. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis , 2016, European heart journal.
[30] M. Boutjdir,et al. Arrhythmogenicity of Anti-Ro/SSA Antibodies in Patients With Torsades de Pointes , 2016, Circulation. Arrhythmia and electrophysiology.
[31] X. Tu,et al. Regulation of SCN3B/scn3b by Interleukin 2 (IL-2): IL-2 modulates SCN3B/scn3b transcript expression and increases sodium current in myocardial cells , 2016, BMC Cardiovascular Disorders.
[32] T. Jernberg,et al. Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome. , 2015, European heart journal.
[33] C. January,et al. Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome , 2015, Circulation.
[34] P. Lazzerini,et al. Long QT Syndrome: An Emerging Role for Inflammation and Immunity , 2015, Front. Cardiovasc. Med..
[35] W. Yuan,et al. Effects of C-reactive protein on K(+) channel interaction protein 2 in cardiomyocytes. , 2015, American journal of translational research.
[36] P. Matthews,et al. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping. , 2015, JACC. Cardiovascular imaging.
[37] G. Kitas,et al. Association Between Corrected QT Interval and Inflammatory Cytokines in Rheumatoid Arthritis , 2015, The Journal of Rheumatology.
[38] P. Lazzerini,et al. Antiarrhythmic Potential of Anticytokine Therapy in Rheumatoid Arthritis: Tocilizumab Reduces Corrected QT Interval by Controlling Systemic Inflammation , 2015, Arthritis care & research.
[39] P. Libby,et al. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. , 2015, European heart journal.
[40] N. Sattar,et al. An Evaluation of Risk Factors for Major Adverse Cardiovascular Events During Tocilizumab Therapy , 2015, Arthritis & rheumatology.
[41] W. Gulliver,et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis , 2015, Annals of the rheumatic diseases.
[42] George D Kitas,et al. Autonomic function and rheumatoid arthritis: a systematic review. , 2014, Seminars in arthritis and rheumatism.
[43] H. Karagueuzian,et al. Cardiac fibrosis as a determinant of ventricular tachyarrhythmias , 2014, Journal of arrhythmia.
[44] P. Lazzerini,et al. Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. , 2014, Autoimmunity reviews.
[45] M. Zile,et al. Cardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy. , 2014, American journal of physiology. Heart and circulatory physiology.
[46] Rahul Jain,et al. Fragmented ECG as a Risk Marker in Cardiovascular Diseases , 2014, Current cardiology reviews.
[47] M. Wahren-Herlenius,et al. Molecular mechanisms of congenital heart block. , 2014, Experimental cell research.
[48] C. Fiset,et al. Interleukin-1β Reduces L-type Ca2+ Current through Protein Kinase Cϵ Activation in Mouse Heart* , 2014, The Journal of Biological Chemistry.
[49] L. Klein,et al. Sudden cardiac death in heart failure. , 2014, Cardiology clinics.
[50] M. Jiang,et al. [Ca2+]i Elevation and Oxidative Stress Induce KCNQ1 Protein Translocation from the Cytosol to the Cell Surface and Increase Slow Delayed Rectifier (IKs) in Cardiac Myocytes* , 2013, The Journal of Biological Chemistry.
[51] F. Charpentier,et al. Identifying potential functional impact of mutations and polymorphisms: linking heart failure, increased risk of arrhythmias and sudden cardiac death , 2013, Front. Physiol..
[52] M. Budoff,et al. Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease , 2013, Annals of the rheumatic diseases.
[53] P. Lazzerini,et al. Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. , 2013, European journal of internal medicine.
[54] T. Therneau,et al. Longterm Outcomes and Treatment After Myocardial Infarction in Patients with Rheumatoid Arthritis , 2013, The Journal of Rheumatology.
[55] T. Glant,et al. Genetics of Rheumatoid Arthritis — A Comprehensive Review , 2013, Clinical Reviews in Allergy & Immunology.
[56] S. Banik,et al. Pharmacotherapy Options in Rheumatoid Arthritis , 2013, Clinical medicine insights. Arthritis and musculoskeletal disorders.
[57] K. Deepak,et al. A pilot study on short term heart rate variability & its correlation with disease activity in Indian patients with rheumatoid arthritis , 2012, The Indian journal of medical research.
[58] D. Rosenbaum,et al. Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction. , 2012, Journal of the American College of Cardiology.
[59] A. Çelik,et al. Frequency of fragmented QRS on ECG is increased in patients with rheumatoid arthritis without cardiovascular disease: a pilot study , 2012, Modern rheumatology.
[60] M Juhani Junttila,et al. Sudden Cardiac Death Caused by Coronary Heart Disease , 2012, Circulation.
[61] G. Eisenhofer,et al. Autonomic Nervous System Function in Rheumatoid Arthritis , 2012, Cellular and molecular neurobiology.
[62] Candido Cabo,et al. Myofibroblasts cause heterogeneous Cx43 reduction and are unlikely to be coupled to myocytes in the healing canine infarct. , 2012, American journal of physiology. Heart and circulatory physiology.
[63] H. Evrengul,et al. Effect of Infliximab Treatment on QT Intervals in Patients With Ankylosing Spondylitis , 2011, Journal of Investigative Medicine.
[64] P. Lazzerini,et al. Anti‐Ro/SSA–associated corrected QT interval prolongation in adults: The role of antibody level and specificity , 2011, Arthritis care & research.
[65] A. Pfeufer,et al. Inherited cardiac arrhythmias: diagnosis, treatment, and prevention. , 2011, Deutsches Arzteblatt international.
[66] Jacques M. T. de Bakker,et al. Fibrosis and Cardiac Arrhythmias , 2011 .
[67] Y. Liao,et al. Effect of Tumor Necrosis Factor-α on Neutralization of Ventricular Fibrillation in Rats with Acute Myocardial Infarction , 2011, Mediators of inflammation.
[68] K. Yodogawa,et al. Effect of Corticosteroid Therapy on Ventricular Arrhythmias in Patients with Cardiac Sarcoidosis , 2011, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[69] C. Çevik,et al. Fragmented QRS Complexes Are Associated with Cardiac Fibrosis and Significant Intraventricular Systolic Dyssynchrony in Nonischemic Dilated Cardiomyopathy Patients with a Narrow QRS Interval , 2011, Echocardiography.
[70] J. Lima,et al. Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study , 2010, Arthritis research & therapy.
[71] S. Harrison,et al. TNF-α and IL-1β increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes , 2010, Cell calcium.
[72] E. Terzioğlu,et al. Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus , 2010, Lupus.
[73] U. Eriksson,et al. Mechanisms of cardiac fibrosis in inflammatory heart disease. , 2009, Trends in cardiovascular medicine.
[74] U. Eriksson,et al. Heart-Infiltrating Prominin-1+/CD133+ Progenitor Cells Represent the Cellular Source of Transforming Growth Factor &bgr;–Mediated Cardiac Fibrosis in Experimental Autoimmune Myocarditis , 2009, Circulation research.
[75] S. Grandy,et al. Ventricular K+ currents are reduced in mice with elevated levels of serum TNFalpha. , 2009, Journal of molecular and cellular cardiology.
[76] R. Gallucci,et al. Interleukin (IL)‐6 modulates transforming growth factor‐β expression in skin and dermal fibroblasts from IL‐6‐deficient mice , 2009, The British journal of dermatology.
[77] H. Kestler,et al. Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy , 2009, European heart journal.
[78] P. Lazzerini,et al. Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, crossover study in patients with chronic arthritis. , 2008, The Journal of rheumatology.
[79] H. John,et al. Hypertension in rheumatoid arthritis. , 2008, Rheumatology.
[80] J. Armitage,et al. Acute coronary syndromes complicating the first infusion of rituximab. , 2008, Clinical lymphoma & myeloma.
[81] Takahiko Horiuchi,et al. Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab. , 2008, Arthritis and rheumatism.
[82] Marmar Vaseghi,et al. The role of the autonomic nervous system in sudden cardiac death. , 2008, Progress in cardiovascular diseases.
[83] Peter Nightingale,et al. Lymphotoxin 252A>G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritis , 2008, Annals of the rheumatic diseases.
[84] G. Citera,et al. Clinical significance of anti-Ro antibodies in rheumatoid arthritis , 2008, Clinical Rheumatology.
[85] T. Hirano,et al. SHP2-mediated signaling cascade through gp130 is essential for LIF-dependent I CaL, [Ca2+]i transient, and APD increase in cardiomyocytes. , 2007, Journal of molecular and cellular cardiology.
[86] H. Morita,et al. Anti-KCNH2 antibody-induced long QT syndrome: novel acquired form of long QT syndrome. , 2007, Journal of the American College of Cardiology.
[87] M. Borggrefe,et al. Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients--a pilot study. , 2007, Cytokine.
[88] K. Wahbi,et al. Myocardial dysfunction in rheumatoid arthritis: a controlled tissue-Doppler echocardiography study. , 2007, The Journal of rheumatology.
[89] A. Silman,et al. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register , 2007, Arthritis and rheumatism.
[90] N. Shostak,et al. Heart rate variability is related to disease activity and smoking in rheumatoid arthritis patients , 2007, International journal of clinical practice.
[91] M. Duru,et al. P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters , 2007, Rheumatology International.
[92] O. Hurtado,et al. TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation. , 2007, American journal of physiology. Heart and circulatory physiology.
[93] R. Price,et al. Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor. , 2007, American journal of physiology. Heart and circulatory physiology.
[94] W. Ollier,et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. , 2007, Arthritis and rheumatism.
[95] C. Long,et al. IL-1beta stimulates rat cardiac fibroblast migration via MAP kinase pathways. , 2007, American journal of physiology. Heart and circulatory physiology.
[96] P. Seferovic,et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. , 2006, Rheumatology.
[97] C. Brand,et al. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. , 2006, Arthritis and rheumatism.
[98] Gani Bajraktari,et al. Left and right ventricular diastolic functions in patients with rheumatoid arthritis without clinically evident cardiovascular disease , 2006, International journal of clinical practice.
[99] M. Horie,et al. Tumor necrosis factor-alpha inhibits the cardiac delayed rectifier K current via the asphingomyelin pathway. , 2006, Biochemical and biophysical research communications.
[100] K. Kawahara,et al. Tumor Necrosis Factor-α Downregulates the Voltage Gated Outward K+ Current in Cultured Neonatal Rat Cardiomyocytes , 2006 .
[101] G. Salama,et al. Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha. , 2006, American journal of physiology. Heart and circulatory physiology.
[102] Ş. Arslan,et al. Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease , 2006, Clinical Rheumatology.
[103] G. Lip,et al. Left ventricular systolic dysfunction in rheumatoid disease: an unrecognized burden? , 2006, Journal of the American College of Cardiology.
[104] M. Lapeyre-Mestre,et al. [Cardiac effects of cytokines produced after rituximab infusion]. , 2005, Bulletin du cancer.
[105] B. Greenberg,et al. Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblasts. , 2005, American journal of physiology. Heart and circulatory physiology.
[106] J. Lecron,et al. Role of interleukin‐6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation , 2005, Journal of cellular physiology.
[107] N. Goodson,et al. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s , 2005, Annals of the rheumatic diseases.
[108] G. Kitas,et al. Reversing myocardial microvascular disease in a patient with rheumatoid arthritis. , 2005, The Journal of rheumatology.
[109] S. Gabriel,et al. Cardiovascular death in rheumatoid arthritis: a population-based study. , 2005, Arthritis and rheumatism.
[110] D. Kem,et al. Tumor Necrosis Factor α, Rapid Ventricular Tachyarrhythmias, and Infarct Size in Canine Models of Myocardial Infarction , 2005, Journal of cardiovascular pharmacology.
[111] S. Gabriel,et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. , 2005, Arthritis and rheumatism.
[112] S. Ball,et al. Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. , 2004, Cardiovascular research.
[113] A. Gnasso,et al. Effect of anti TNFalpha therapy on arterial diameter and wall shear stress and HDL cholesterol. , 2004, Atherosclerosis.
[114] B. Polat,et al. Heart rate variability in patients with rheumatoid arthritis , 2004, Rheumatology International.
[115] Hui-zhen Wang,et al. Impairment of HERG K+ Channel Function by Tumor Necrosis Factor-α , 2004, Journal of Biological Chemistry.
[116] P. Lazzerini,et al. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. , 2004, Arthritis and rheumatism.
[117] R. Wojtala,et al. The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis , 2004, Clinical Rheumatology.
[118] W. Ollier,et al. Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. , 2004, Seminars in arthritis and rheumatism.
[119] M. Braun,et al. Case Reports of Heart Failure after Therapy with a Tumor Necrosis Factor Antagonist , 2003, Annals of Internal Medicine.
[120] J. Francis,et al. Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[121] R. Maestri,et al. Short-Term Heart Rate Variability Strongly Predicts Sudden Cardiac Death in Chronic Heart Failure Patients , 2003, Circulation.
[122] V. Shusterman,et al. Calcium-dependent arrhythmias in transgenic mice with heart failure. , 2003, American journal of physiology. Heart and circulatory physiology.
[123] Kevin J. Tracey,et al. The inflammatory reflex , 2002, Nature.
[124] A. Silman,et al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. , 2002, Rheumatology.
[125] A. Silman,et al. Epidemiology and genetics of rheumatoid arthritis , 2002, Arthritis research.
[126] H. Jongsma,et al. Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets. , 2002, Cardiovascular research.
[127] A. Cindaş,et al. QT dispersion and cardiac involvement in patients with rheumatoid arthritis , 2002, Scandinavian Journal of Rheumatology.
[128] D. Mann,et al. Left Ventricular Remodeling in Transgenic Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor , 2001, Circulation.
[129] M. Boutjdir,et al. Down‐regulation of L‐type calcium channel in pups born to 52 kDa SSA/Ro immunized rabbits , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[130] M. Boutjdir,et al. Autoantibodies from mothers of children with congenital heart block downregulate cardiac L-type Ca channels. , 2001, Journal of molecular and cellular cardiology.
[131] S. Maier,et al. Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1β protein in rats , 2000, Autonomic Neuroscience.
[132] V. Diehl,et al. CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8) , 2016 .
[133] K. A. Yamada,et al. Mechanisms of remodeling of gap junction distributions and the development of anatomic substrates of arrhythmias. , 1999, Cardiovascular research.
[134] A. Maio,et al. Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. , 1999, Cytokine.
[135] B. Komşuoğlu,et al. Dispersion of ventricular repolarization: a new marker of ventricular arrhythmias in patients with rheumatoid arthritis. , 1998, The Journal of rheumatology.
[136] D. Vergani,et al. Autonomic nervous dysfunction in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA): possible pathogenic role of autoantibodies to autonomic nervous structures , 1997, Clinical and experimental immunology.
[137] A. Koretsky,et al. Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .
[138] K M Kessler,et al. Frequency of sudden cardiac death and profiles of risk. , 1997, The American journal of cardiology.
[139] H. Oral,et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.
[140] Steven F. Maier,et al. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication , 1995, Neuroscience Letters.
[141] G. Rozanski,et al. Interleukin-1 enhances beta-responsiveness of cardiac L-type calcium current suppressed by acidosis. , 1994, American Journal of Physiology.
[142] Y. -. Li,et al. Effects of human recombinant interleukin-1 on electrical properties of guinea pig ventricular cells. , 1993, Cardiovascular research.
[143] Y. Oomura,et al. The effects of interleukin-1 beta on the activity of adrenal, splenic and renal sympathetic nerves in the rat. , 1991, Journal of the autonomic nervous system.
[144] F. Bianchi,et al. Antibodies to cardiac conducting tissue and abnormalities of cardiac conduction in rheumatoid arthritis. , 1983, Clinical and experimental immunology.
[145] E. Atwater,et al. Heart disease in patients with seropositive rheumatoid arthritis; a controlled autopsy study and review. , 1969, Archives of internal medicine.
[146] P. Bennett,et al. Autonomic Neuropathy in Rheumatoid Arthritis , 1965, Annals of the rheumatic diseases.
[147] B. Cruickshank. Heart lesions in rheumatoid disease. , 1958, The Journal of pathology and bacteriology.
[148] Xiuhua Wang,et al. Tissue Inhibitor of Matrix Metalloproteinase-1 Promotes Myocardial Fibrosis by Mediating CD63–Integrin &bgr;1 Interaction , 2017, Hypertension.
[149] M. Lindsey,et al. Atherosclerosis exacerbates arrhythmia following myocardial infarction: Role of myocardial inflammation. , 2015, Heart rhythm.
[150] P. Krishan,et al. Interleukin-6 blockade improves autonomic dysfunction in rheumatoid arthritis. , 2015, Acta reumatologica portuguesa.
[151] Özcan Özgür Ulaș,et al. Ventricular arrhythmia with cessation of infliximab in a patient with ankylosing spondylitis , 2015 .
[152] S. Gabriel,et al. Population-based study of QT interval prolongation in patients with rheumatoid arthritis. , 2015, Clinical and experimental rheumatology.
[153] G. Kitas,et al. Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. , 2014, Rheumatology.
[154] K. Midwood,et al. Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. , 2012, Rheumatology.
[155] R. Cattaneo,et al. Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations. , 2006, Clinical and experimental rheumatology.
[156] C. Tovar,et al. c-Fos generation in the dorsal vagal complex after systemic endotoxin is not dependent on the vagus nerve. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.
[157] E. Kentala,et al. Electrocardiographic findings in patients with connective tissue disease. , 1978, Scandinavian journal of rheumatology.